SCHEMBL24543299

SCHEMBL24543299

COCc1ccc(-c2ccc(NC(=O)C(C)(C)Oc3ccc(C(F)(F)F)cc3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 8/20 0.54
▸ PPARD Q03181 5/20 0.54
▸ PPARG P37231 4/20 0.54
▸ TRPV1 Q8NER1 2/20 0.49
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ KIF11 P52732 1/20 0.45
▸ CNR1 P21554 1/20 0.43
▸ ADAMTS4 O75173 1/20 0.43
▸ MMP13 P45452 1/20 0.43
▸ MDH1 P40925 1/20 0.43
▸ MDH2 P40926 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ MAPT P10636 1/20 0.42
▸ PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24542758 0.88 PPARA (0.52) PPARAPPARDPPARGLMNACYP1A2
SCHEMBL24543016 0.88 PPARA (0.51) PPARAPPARDPPARGLMNACYP1A2
SCHEMBL24543029 0.87 PPARA (0.50) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542787 0.87 PPARA (0.50) PPARALMNACYP1A2CYP3A4CYP2D6
SCHEMBL24543049 0.87 KIF11 (0.45) PPARAPPARDPPARGLMNAHTT
SCHEMBL24542755 0.86 CYP1A2 (0.60) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542785 0.86 PPARA (0.49) PPARALMNACYP1A2CYP3A4CYP2D6
SCHEMBL24542753 0.86 PPARA (0.57) PPARAPPARGCYP1A2CYP3A4CYP2D6
SCHEMBL24543063 0.85 PPARA (0.54) PPARALMNAHTTCYP1A2CYP3A4
SCHEMBL24542766 0.84 TRPV1 (0.54) PPARAPPARDPPARGTRPV1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARMACEUTICALS INC. 2024-04-25 — — US disclosed
WO-2022129933-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 Pandeia Therapeutics Limited (GB) 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 GPR88, GPR65, GPR68 PPARA 355/4885PPARD 408/4885PPARG 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback